ID   UT44
AC   CVCL_VJ99
DR   CCRID; 1101HUM-PUMC000601
DR   Cosmic; 2653722
DR   Wikidata; Q98134385
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000601; PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,24
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D21S11: 31,33.2
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 11,14
ST   D7S820: 11,12
ST   D8S1179: 16
ST   FGA: 24
ST   Penta E: 18,22
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 8
//
RX   PubMed=28256713; DOI=10.1002/ijc.30674;
RA   Feng, Hai-Liang
RA   Zhang, Yu
RA   Liu, Kan
RA   Zhu, Yan
RA   Yang, Zhen-Li
RA   Zhang, Xu
RA   Liu, Yu-Qin
RT   "Intrinsic gene changes determine the successful establishment of
RT   stable renal cancer cell lines from tumor tissue.";
RL   Int. J. Cancer 140:2526-2534(2017).
//